Relapse Prevention, RoW: Study to Evaluate Prevention of Relapse in Patients in Stable Chronic Schizophrenia Receiving Either Seroquel or Placebo

This study has been completed.

Study NCT00228462 Information provided by AstraZeneca

First Received: September 27, 2005 Last Updated: December 14, 2007 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been completed.
Study Completion Date:	April 2006
Estimated Primary Completion Date:	No date given